
(Left to right) Ben Shen led the study with Hindra, Jeffrey D. Rudolf, Ivana Crnov?i?, Dong Yang, Xiaohui Yan, Xiuling Li and Christoph Rader on the Florida campus of The Scripps Research Institute.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed an efficient process to rapidly discover new “enediyne natural products” from soil microbes that could be further developed into extremely potent anticancer drugs.
The study highlights microbial natural products as abundant sources of new drug leads. The researchers’ discovery process involves prioritizing the microbes from the TSRI strain collection and focusing on the ones that are genetically predisposed to produce specific families of natural products. The scientists say this process saves time and resources in comparison to the traditional approaches used to identify these rare molecules.
The study, led by TSRI Professor Ben Shen, was published today in the journal mBio.
Shen and his colleagues uncovered a new family of enediyne natural products, called tiancimycins, (TNMs) which kill selected cancer cells more rapidly and completely in comparison to toxic molecules used in FDA-approved antibody-drug conjugates (ADCs)— monoclonal antibodies attached to cytotoxic drugs that target only cancer cells.
The scientists also discovered several new producers of C-1027, an antitumor antibiotic currently in clinical development, which can produce C-1027 at much higher levels.
It has been more than a decade since Shen first reported on the C-1027 enediyne biosynthetic machinery, and he speculated then that the knowledge obtained from studying biosynthesis of C-1027, and other enediynes, could be used for the discovery of novel enediyne natural products.
“The enediynes represent one of the most fascinating families of natural products for their extraordinary biological activities,” Shen said. “By surveying 3,400 strains from the TSRI collection, we were able to identify 81 strains that harbor genes encoding enediynes. With what we know, we can predict novel structural insights that can be exploited to radically accelerate enediyne-based drug discovery and development.”
“The work described by the Shen group is an excellent example of what can be achieved by coupling state of the art genomic analyses of potential biosynthetic clusters and modern physicochemical techniques,” said David J. Newman, retired chief of the National Cancer Institute’s Natural Products Branch. “As a result of their work, the potential number of enediynes has significantly increased.”
Shen’s method of strain prioritization and genome mining means a far more efficient use of resources involved in the discovery process, targeting only those strains that look to produce the most important natural compounds.
“This study shows that the potential to rapidly discover new enediyne natural products from a large strain collection is within our reach,” said TSRI Research Associate Xiaohui Yan, one of four first authors of the study. “We also show the feasibility of manipulating tiancimycin biosynthesis in vivo, which means that sufficient quantities of these precious natural products can be reliably produced by microbial fermentation for drug development and eventual commercialization.”
Learn more: Scripps Florida Scientists Discover New Natural Source of Potent Anti-Cancer Drugs
Receive an email update when we add a new ANTI-CANCER DRUG article.
The Latest on: Anticancer drug
via Google News
The Latest on: Anticancer drug
- Novel dual-targeting drug could become a next-generation treatment for EBV-related cancerson March 2, 2021 at 3:15 pm
A Hong Kong Baptist University-led research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein-Barr virus (EBV).
- Emmaus Life Sciences Announces Collaboration with Kainos Medicine for Preclinical Development of IRAK4 Inhibitor as Potential Anti-Cancer Drugon March 2, 2021 at 8:59 am
Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today that it has entered into an agreement with ...
- Computational modelling of nanotube delivery of anti-cancer drug into glutathione reductase enzymeon March 2, 2021 at 8:48 am
Density functional theory method combined with docking and molecular dynamics simulations are used to understand the interaction of carmustine with human glutathione reductase enzyme. The active site ...
- Kidney-on-a-chip offers clues to prevent kidney damage from essential drugson March 2, 2021 at 6:40 am
There are 1.5 million cases of drug-induced kidney toxicity each year in the U.S. Among the usual suspects are cyclosporin and cisplatin, a pair of widely used chemotherapy drugs. Because both are ...
- HKBU develops dual-targeting drug for EBV-related cancerson March 2, 2021 at 6:36 am
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein-Barr virus (EBV).
- Anticancer Biosciences is developing a new antimitotic cancer therapeutics using natural productson March 1, 2021 at 11:13 pm
Anticancer Biosciences is applying its synthetic lethality expertise for better cancer therapies. The identification of novel antimitotic agents that do not lead to severe side effects is much ...
- FDA-approved antidiarrhea drug can reverse resistance to chemotherapy in a mouse model of leukemiaon March 1, 2021 at 10:31 am
New research into one of the most common and difficult cancers to treat has revealed an effective route to mitigating chemotherapy resistance through the use of a drug already approved by the FDA to ...
- Global Small Molecule Targeted Anti-cancer Drug Market 2020 - 2025 Research Study Provides Projections of COVID-19 Pandemic in its New Reporton February 28, 2021 at 10:35 pm
Global Small Molecule Targeted Anti-cancer Drug Market 2020 by Company, Regions, Type and Application, Forecast ...
- Researchers watch anti-cancer drug release from DNA nanostructures in real timeon February 28, 2021 at 4:00 pm
DNA nanotechnology—the research field using DNA molecules as building material—has developed rapidly during recent years and enabled the construction of increasingly complex nanostructures. DNA ...
via Bing News
One Comment
Robert
They should have a look at the research being done at Washington U in St Louis with a substance
found in bee venom, mellitin. It has been found to be effective against cancer, alzheimers and HIV.